Beginning of the month Berkshire-Hathaway exceeded the market capitalization of $1 trillion, becoming the primary ...
Eli Lilly launched a brand new type of its weight-loss drug Zepbound on Tuesday for ...
Novo Nordisk And Eli Lilly currently dominate the booming marketplace for a category of medicine ...
Investors need to know if Eli Lilly will face the identical pricing pressure on its ...
Eli Lilly reported on Thursday Second quarter results and revenue exceeded all expectations, raising full-year ...
The lucrative weight-loss drug market won't remain a duopoly eternally. With billions at stake, that ...
Good morning! Eli Lilly, Novo Nordisk and other pharmaceutical corporations presented encouraging data on weight-loss ...
Eli Lilly announced on Friday that it has applied for U.S. approval of its weight-loss ...
The rapidly increasing demand for a category of weight reduction and diabetes drugs has Eli ...
Eli Lilly announced on Friday that the corporate has invested an extra $5.3 billion in ...